ArticleBioprocess and biosystems engineering2025
Process development for antifungal production by Bacillus subtilis BS20: nanoparticle supplementation, process optimization and preliminary scale-up studies.
Article in Bioprocess and biosystems engineering, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The intensive agricultural practices used to meet global crop production demands have resulted in rigorous use of chemical pesticides. These ultimately compromise crop production as well as the environment. To alleviate these challenges, cheaper and environmentally friendly biocontrol agents have been considered as an alternative to chemical pesticides. Hence, this study was undertaken with the aim of enhancing antifungal production by Bacillus subtilis BS20 through process modeling, optimization, nanocatalysis and subsequent assessment of the scale up potential of the optimized process. The investigated process parameters included glucose concentration (10-30 g/L), incubation temperature (25-45 ℃) and incubation time (24-96 h). Optimized process conditions of 11.5 g/L glucose concentration, 24 h incubation time and 41 °C incubation temperature produced maximal antifungal activity of 68 mm zone of inhibition. Moreover, the inclusion of nanoparticles favored increased biomass yield but low antifungal activity. Additionally, constant power consumption, Reynolds number (Re) and impeller tip (V
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.